Bishal Kumar Dey

Employment

• Institute of Post Graduate Medical Education and Research Senior Research Fellow
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Recent advances in the diagnosis of Turner syndrome karyotype with primary amenorrhoea
  SN Comprehensive Clinical Medicine 2026 DOI: 10.1007/s42399-026-02642-y
  +Save
• Adipogenic Differentiation of Fibrocytes and its Association With Disease Activity in Graves’ Orbitopathy
  SN Comprehensive Clinical Medicine 2026 DOI: 10.1007/s42399-026-02425-5
  +Save
• Gestational diabetes mellitus: Bridging research gaps through a translational framework
  Annals of Medical Science & Research 2026 DOI: 10.4103/amsr.amsr_30_26
  +Save
• Expression of long non-coding RNAs MALAT1, MEG3, and XIST in gestational diabetes mellitus: a cross-sectional study
  Acta Diabetologica 2026 DOI: 10.1007/s00592-025-02581-5
  +Save
• Fatty acid binding protein 4 as a diagnostic biomarker for peripheral arterial disease in type 2 diabetes: a cross-sectional study
  BMC Cardiovascular Disorders 2025 DOI: 10.1186/s12872-025-05468-z
  +Save
• Apelin: a possible factor may be involved in the development of Gestational Diabetes Mellitus
  Diabetes Research and Clinical Practice 2025 DOI: 10.1016/j.diabres.2025.112883
  +Save
• Dapagliflozin induces corneal nerve regeneration in subjects with type 2 diabetes by altering the AGE/RAGE pathway
  Diabetes Research and Clinical Practice 2025 DOI: 10.1016/j.diabres.2025.112552
  +Save
• A Critical Review on Varied Aspects of Gestational Diabetes Mellitus (GDM) and It's Associations with Placenta
  Indian Journal of Endocrinology and Metabolism 2025 DOI: 10.4103/ijem.ijem_453_24
  +Save
• The Importance of Fatty acid binding protein 4 (FABP4) in the diagnosis of Peripheral Arterial Disease (PAD) in the presence of Type 2 Diabetes (T2D)
  Research Square 2025 DOI: 10.21203/rs.3.rs-7306668/v1
  +Save
• Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of GDM (gestational diabetes mellitus)
  Diabetes and Metabolic Syndrome Clinical Research and Reviews 2024 DOI: 10.1016/j.dsx.2024.103019
  +Save